319 related articles for article (PubMed ID: 28767139)
21. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in colorectal cancer.
Gennari L; Doci R; Rossetti C
Hepatogastroenterology; 2000; 47(32):310-4. PubMed ID: 10791178
[TBL] [Abstract][Full Text] [Related]
23. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S
Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464
[TBL] [Abstract][Full Text] [Related]
24. Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.
Mahar AL; Compton C; McShane LM; Halabi S; Asamura H; Rami-Porta R; Groome PA;
J Thorac Oncol; 2015 Nov; 10(11):1576-89. PubMed ID: 26313682
[TBL] [Abstract][Full Text] [Related]
25. Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review.
Pathak S; Nunes QM; Daniels IR; Smart NJ
Colorectal Dis; 2014 Oct; 16(10):769-76. PubMed ID: 25039573
[TBL] [Abstract][Full Text] [Related]
26. Does young age influence the prognosis of colorectal cancer: a population-based analysis.
McKay A; Donaleshen J; Helewa RM; Park J; Wirtzfeld D; Hochman D; Singh H; Turner D
World J Surg Oncol; 2014 Dec; 12():370. PubMed ID: 25466394
[TBL] [Abstract][Full Text] [Related]
27. Nomogram for predicting recurrence in stage II colorectal cancer.
Hoshino N; Hasegawa S; Hida K; Kawada K; Ganeko R; Sugihara K; Sakai Y
Acta Oncol; 2016 Dec; 55(12):1414-1417. PubMed ID: 27581839
[TBL] [Abstract][Full Text] [Related]
28. Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Cashin PH; Graf W; Nygren P; Mahteme H
Ann Surg Oncol; 2013 Dec; 20(13):4183-9. PubMed ID: 23975316
[TBL] [Abstract][Full Text] [Related]
29. Survival Analysis and Prognostic Factors for Colorectal Cancer Patients in Malaysia.
Hassan MR; Suan MA; Soelar SA; Mohammed NS; Ismail I; Ahmad F
Asian Pac J Cancer Prev; 2016; 17(7):3575-81. PubMed ID: 27510011
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases.
Wang XY; Zhang R; Wang Z; Geng Y; Lin J; Ma K; Zuo JL; Lu L; Zhang JB; Zhu WW; Chen JH
Br J Surg; 2019 Dec; 106(13):1747-1760. PubMed ID: 31386192
[TBL] [Abstract][Full Text] [Related]
31. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
32. [The prognostic relevance of tumor localization in colorectal cancer. A multivariate analysis].
Coenen C; Bauer KH; Uffmann M; Wedmann B; Zumtobel V
Z Gastroenterol; 1989 Nov; 27(11):683-5. PubMed ID: 2618116
[TBL] [Abstract][Full Text] [Related]
33. Radioimmunoguided surgery in primary colorectal carcinoma: an intraoperative prognostic tool and adjuvant to traditional staging.
Arnold MW; Young DC; Hitchcock CL; Schneebaum S; Martin EW
Am J Surg; 1995 Oct; 170(4):315-8. PubMed ID: 7573720
[TBL] [Abstract][Full Text] [Related]
34. The promise of biological markers as prognostic determinants in colorectal cancer.
Johnston PG
Onkologie; 2005 Aug; 28(8-9):388-9. PubMed ID: 16160400
[No Abstract] [Full Text] [Related]
35. Characteristics and Prognostic Factors of Bone Metastasis in Patients With Colorectal Cancer.
Kawamura H; Yamaguchi T; Yano Y; Hozumi T; Takaki Y; Matsumoto H; Nakano D; Takahashi K
Dis Colon Rectum; 2018 Jun; 61(6):673-678. PubMed ID: 29722726
[TBL] [Abstract][Full Text] [Related]
36. Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer.
Xu W; Zhu Y; Shen W; Ding W; Wu T; Guo Y; Chen X; Zhou M; Chen Y; Cui L; Du P
J Int Med Res; 2019 May; 47(5):1829-1842. PubMed ID: 30616445
[TBL] [Abstract][Full Text] [Related]
37. Telomere Length as a Prognostic Factor for Overall Survival in Colorectal Cancer Patients.
Jia H; Wang Z
Cell Physiol Biochem; 2016; 38(1):122-8. PubMed ID: 26741140
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis.
Sloothaak DA; Sahami S; van der Zaag-Loonen HJ; van der Zaag ES; Tanis PJ; Bemelman WA; Buskens CJ
Eur J Surg Oncol; 2014 Mar; 40(3):263-9. PubMed ID: 24368050
[TBL] [Abstract][Full Text] [Related]
39. Classifying the stage IV colorectal cancer: prognostic impact of radical resection for colorectal liver metastases and proposal for a new staging system.
Chen YG; Liu Z; Wang XS
Cell Biochem Biophys; 2013; 67(3):1445-9. PubMed ID: 23532608
[TBL] [Abstract][Full Text] [Related]
40. Molecular subtyping improves prognostication of Stage 2 colorectal cancer.
Purcell RV; Schmeier S; Lau YC; Pearson JF; Frizelle FA
BMC Cancer; 2019 Nov; 19(1):1155. PubMed ID: 31775679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
